Wang H, Zheng J, Pan J, Li S, et al. Neoadjuvant triple-modality therapy with immune checkpoint blockade, anti-angiogenesis, and chemotherapy enhances pathologic response and survival in locally advanced and metastatic colorectal cancer: a multicenter cohort study. Int J Colorectal Dis 2025;40:154.
PMID: 40632233